Cancer Research AACR Legacy  EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 33, 1113-1118, May 1, 1973]
© 1973 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brown, G. B.
Right arrow Articles by Stöhrer, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brown, G. B.
Right arrow Articles by Stöhrer, G.

Correlations between Oncogenic and Chemical Properties of Several Derivatives of 3-Hydroxyxanthine and 3-Hydroxyguanine1

George Bosworth Brown, Morris N. Teller, Irene Smullyan, Nigel J. M. Birdsall, Tzoong-Chyh Lee, James C. Parham and Gerhard Stöhrer

Divisions of Biological Chemistry [G. B. B., N. J. M. B., T.-C. L., J. C. P., G. S.] and Experimental Chemotherapy [M. N. T., I. S.], Sloan-Kettering Institute for Cancer Research, New York, New York 10021

Comparative assays of the oncogenicities of a series of N-methyl and other derivatives of 3-hydroxyxanthine and 3-hydroxyguanine have been carried out. The oncogenicities are directly correlated with the chemical reactivities of esters of those derivatives in water at temperatures and pH's approaching physiological. The oncogenic 3-hydroxypurine derivatives yield anions, which subsequently undergo either a reaction with nucleophilic groups via an ionic substitution mechanism or one via a reduction that appears to result from a free radical mechanism. Serious consideration should be given to each highly reactive intermediate, the free radical and the ionic, as candidate for the agent responsible for inducing the oncogenic process.

1 This investigation was supported in part by the National Cancer Institute (Grant CA 08748), the American Cancer Society (Grant BC-32), and the Atomic Energy Commission [Contract AT(11-1)-3521]. Portions were presented at the Annual Meetings of the American Association for Cancer Research (9, 10). This is Contribution 50 in a series on "Purine N-Oxides."

Received 12/ 8/72. Accepted 2/15/73.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1973 by the American Association for Cancer Research.